GLOW (GHK-Cu · BPC-157 · TB-500)
Also known as GLOW blend, GHK-Cu BPC-157 TB-500 blend
GLOW is a fixed research blend of GHK-Cu, BPC-157, and TB-500 — three compounds studied in overlapping tissue-repair and extracellular-matrix contexts. A research-use profile of why they're grouped.
GLOW is not a single molecule but a fixed combination of three separate research compounds prepared together: the copper tripeptide GHK-Cu, the synthetic pentadecapeptide BPC-157, and the thymosin β4 fragment TB-500. A blend page has a different job than a single-compound page — the useful question is not 'what is this molecule' but 'why are these three grouped.'
This page answers that. It describes each component briefly and, more importantly, the shared research theme that puts them in the same vial. It makes no claim that combining them produces any effect; it explains the rationale researchers cite for studying them in overlapping contexts. Each component has its own full monograph, linked below.
The three components
GHK-Cu is a copper-binding tripeptide (glycyl-histidyl-lysine complexed with copper) studied in skin-biology and extracellular-matrix research. BPC-157 is a synthetic 15-residue peptide referenced heavily in soft-tissue and gut-lining repair models. TB-500 is a fragment associated with thymosin β4, studied in cell-migration and tissue-repair contexts.
The three are structurally unrelated — a metal-complexed tripeptide, a proline-rich pentadecapeptide, and an actin-binding-protein fragment. Their grouping is thematic, not chemical.
Why these three are combined for research
The unifying thread of GLOW is the tissue-repair and extracellular-matrix theme, with a lean toward skin and connective tissue — which is where the blend's name comes from. GHK-Cu brings the matrix- and skin-biology angle; BPC-157 and TB-500 bring the broader soft-tissue-repair research contexts they are each independently associated with. Grouping them lets a researcher study these overlapping contexts as a set rather than assembling three separate preparations.
It is worth stating plainly what this rationale is and is not. It explains why the components share a research theme. It is not an assertion that the combination yields a combined result — blend behavior is itself an open research question, and nothing here should be read as an outcome claim.
Handling a multi-component blend
A blend introduces handling considerations a single peptide does not: the components are co-lyophilized, and a certificate of analysis should account for each one. GHK-Cu in particular carries a copper complex, which is part of its identity on that certificate. As with any lot, verify against the batch-specific certificate rather than a generic specification.
These are research areas the compound is associated with in the literature — not medical claims or intended uses.
Handling & storage
Supplied as a co-lyophilized blend. Kept sealed, cold, and dry; in research settings reconstituted with bacteriostatic water only when a protocol requires it, then refrigerated. Handle per accepted laboratory practice.
Verify a certificate by lot →Common questions
Three components: GHK-Cu (a copper tripeptide), BPC-157 (a synthetic pentadecapeptide), and TB-500 (a thymosin β4 fragment). Each has its own monograph.
They share a tissue-repair and extracellular-matrix research theme, with a skin- and connective-tissue lean. The grouping is thematic; the components are structurally unrelated.
That is an open research question. This page explains why the components share a research context, not that the combination produces any particular result.
This monograph is a research-use reference. It describes composition and the contexts in which the compound has been studied — it is not medical advice, a description of effects, or a recommendation for use. Sold strictly for laboratory and research use; not for human or animal consumption.